• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共孵育作为一种miRNA负载策略以增强干细胞来源的细胞外囊泡的抗肿瘤作用。

Coincubation as miR-Loading Strategy to Improve the Anti-Tumor Effect of Stem Cell-Derived EVs.

作者信息

Brossa Alessia, Tapparo Marta, Fonsato Valentina, Papadimitriou Elli, Delena Michela, Camussi Giovanni, Bussolati Benedetta

机构信息

Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.

Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.

出版信息

Pharmaceutics. 2021 Jan 8;13(1):76. doi: 10.3390/pharmaceutics13010076.

DOI:10.3390/pharmaceutics13010076
PMID:33429869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7826638/
Abstract

Extracellular vesicles are considered a novel therapeutic tool, due to their ability to transfer their cargoes to target cells. Different strategies to directly load extracellular vesicles with RNA species have been proposed. Electroporation has been used for the loading of non-active vesicles; however, the engineering of vesicles already carrying a therapeutically active cargo is still under investigation. Here, we set up a coincubation method to increase the anti-tumor effect of extracellular vesicles isolated from human liver stem cells (HLSC-EVs). Using the coincubation protocol, vesicles were loaded with the anti-tumor miRNA-145, and their effect was evaluated on renal cancer stem cell invasion. Loaded HLSC-EVs maintained their integrity and miR transfer ability. Loaded miR-145, but not miR-145 alone, was protected by RNAse digestion, possibly due to its binding to RNA-binding proteins on HLSC-EV surface, such as Annexin A2. Moreover, miR-145 coincubated HLSC-EVs were more effective in inhibiting the invasive properties of cancer stem cells, in comparison to naïve vesicles. The protocol reported here exploits a well described property of extracellular vesicles to bind nucleic acids on their surface and protect them from degradation, in order to obtain an effective miRNA loading, thus increasing the activity of therapeutically active naïve extracellular vesicles.

摘要

细胞外囊泡因其能够将其携带的物质转移至靶细胞而被视为一种新型治疗工具。人们已提出了多种将RNA种类直接装载到细胞外囊泡中的策略。电穿孔法已用于装载无活性的囊泡;然而,对已携带治疗活性物质的囊泡进行工程改造仍在研究之中。在此,我们建立了一种共孵育方法,以增强从人肝干细胞分离出的细胞外囊泡(HLSC-EVs)的抗肿瘤作用。使用该共孵育方案,将抗肿瘤miRNA-145装载到囊泡中,并评估其对肾癌干细胞侵袭的影响。装载后的HLSC-EVs保持了其完整性和miR转移能力。装载的miR-145(而非单独的miR-145)受到RNA酶消化的保护,这可能是由于其与HLSC-EV表面的RNA结合蛋白(如膜联蛋白A2)结合。此外,与未处理的囊泡相比,miR-145共孵育的HLSC-EVs在抑制癌干细胞侵袭特性方面更有效。本文报道的方案利用了细胞外囊泡的一种已充分描述的特性,即其能够在表面结合核酸并保护其免受降解,从而实现有效的miRNA装载,进而增强未处理的具有治疗活性的细胞外囊泡的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/0290381e43ab/pharmaceutics-13-00076-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/fa45f8140057/pharmaceutics-13-00076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/4a01acd79c11/pharmaceutics-13-00076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/6562baf0cf0d/pharmaceutics-13-00076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/0290381e43ab/pharmaceutics-13-00076-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/fa45f8140057/pharmaceutics-13-00076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/4a01acd79c11/pharmaceutics-13-00076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/6562baf0cf0d/pharmaceutics-13-00076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b7/7826638/0290381e43ab/pharmaceutics-13-00076-g004.jpg

相似文献

1
Coincubation as miR-Loading Strategy to Improve the Anti-Tumor Effect of Stem Cell-Derived EVs.共孵育作为一种miRNA负载策略以增强干细胞来源的细胞外囊泡的抗肿瘤作用。
Pharmaceutics. 2021 Jan 8;13(1):76. doi: 10.3390/pharmaceutics13010076.
2
Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis.人肝干细胞来源的细胞外囊泡抑制肿瘤血管生成。
Int J Cancer. 2019 Jan 15;144(2):322-333. doi: 10.1002/ijc.31796. Epub 2018 Oct 22.
3
Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs.改善血浆来源细胞外囊泡的负载以封装抗肿瘤微小RNA。
Mol Ther Methods Clin Dev. 2019 Jan 9;13:133-144. doi: 10.1016/j.omtm.2019.01.001. eCollection 2019 Jun 14.
4
Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo.人肝干细胞来源的细胞外囊泡在体内外抑制肾癌细胞干细胞来源的肿瘤生长。
Int J Cancer. 2020 Sep 15;147(6):1694-1706. doi: 10.1002/ijc.32925. Epub 2020 Feb 25.
5
Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype.人肝干细胞衍生的细胞外囊泡靶向肝星状细胞并减弱其促纤维化表型。
Front Cell Dev Biol. 2021 Nov 2;9:777462. doi: 10.3389/fcell.2021.777462. eCollection 2021.
6
Serum Derived Extracellular Vesicles Mediated Delivery of Synthetic miRNAs in Human Endothelial Cells.血清来源的细胞外囊泡介导的合成微小RNA在人内皮细胞中的递送
Front Mol Biosci. 2021 Mar 26;8:636587. doi: 10.3389/fmolb.2021.636587. eCollection 2021.
7
Human liver stem cell-derived extracellular vesicles enhance cancer stem cell sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN combined modulation.人肝干细胞衍生的细胞外囊泡通过Akt/mTOR/PTEN联合调节增强癌症干细胞对酪氨酸激酶抑制剂的敏感性。
Oncotarget. 2018 Nov 16;9(90):36151-36165. doi: 10.18632/oncotarget.26319.
8
Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration.动脉粥样硬化形成的巨噬细胞分泌的细胞外囊泡将 microRNA 转移到抑制细胞迁移。
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):49-63. doi: 10.1161/ATVBAHA.117.309795. Epub 2017 Sep 7.
9
Human Liver Stem Cell Derived Extracellular Vesicles Alleviate Kidney Fibrosis by Interfering with the β-Catenin Pathway through miR29b.人肝干细胞衍生的细胞外囊泡通过 miR29b 干扰 β-连环蛋白通路缓解肾纤维化。
Int J Mol Sci. 2021 Oct 5;22(19):10780. doi: 10.3390/ijms221910780.
10
Optimized Protocol for Plasma-Derived Extracellular Vesicles Loading with Synthetic miRNA Mimic Using Electroporation.使用电穿孔法将合成 miRNA 模拟物加载到血浆来源的细胞外囊泡中的优化方案。
Methods Mol Biol. 2022;2504:219-230. doi: 10.1007/978-1-0716-2341-1_16.

引用本文的文献

1
Extracellular vesicles in intestinal protozoa: hidden mediators of host-parasite communication.肠道原生动物中的细胞外囊泡:宿主-寄生虫通讯的隐藏介质
Gut Pathog. 2025 Aug 28;17(1):69. doi: 10.1186/s13099-025-00747-8.
2
MiR-146a engineered extracellular vesicles derived from mesenchymal stromal cells more potently attenuate ischaemia-reperfusion injury in lung transplantation.源自间充质基质细胞的经工程改造的 miR-146a 细胞外囊泡能更有效地减轻肺移植中的缺血再灌注损伤。
Clin Transl Med. 2025 Apr;15(4):e70298. doi: 10.1002/ctm2.70298.
3
Exploring the significance of extracellular vesicles: Key players in advancing cancer and possible theranostic tools.

本文引用的文献

1
Extracellular Vesicle-Based Nucleic Acid Delivery: Current Cancer Therapeutic Strategies.基于细胞外囊泡的核酸递送:当前的癌症治疗策略
Pharmaceutics. 2020 Oct 16;12(10):980. doi: 10.3390/pharmaceutics12100980.
2
Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.细胞外囊泡作为一种高效、多功能的药物递送系统。
Cells. 2020 Sep 29;9(10):2191. doi: 10.3390/cells9102191.
3
Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
探索细胞外囊泡的重要性:癌症进展中的关键参与者及潜在的诊疗工具。
Cancer Pathog Ther. 2024 Apr 25;3(2):109-119. doi: 10.1016/j.cpt.2024.04.005. eCollection 2025 Mar.
4
Exosomes as promising frontier approaches in future cancer therapy.外泌体作为未来癌症治疗中颇具前景的前沿方法。
World J Gastrointest Oncol. 2025 Jan 15;17(1):100713. doi: 10.4251/wjgo.v17.i1.100713.
5
Progress on the Regulation of the Host Immune Response by Parasite-Derived Exosomes.寄生虫衍生外泌体对宿主免疫反应的调节研究进展
Pathogens. 2024 Jul 26;13(8):623. doi: 10.3390/pathogens13080623.
6
mRNA Technology and Mucosal Immunization.信使核糖核酸技术与黏膜免疫
Vaccines (Basel). 2024 Jun 17;12(6):670. doi: 10.3390/vaccines12060670.
7
Exosomal MicroRNAs: Biomarkers of moyamoya disease and involvement in vascular cytoskeleton reconstruction.外泌体微小RNA:烟雾病的生物标志物及其在血管细胞骨架重建中的作用
Heliyon. 2024 May 28;10(11):e32022. doi: 10.1016/j.heliyon.2024.e32022. eCollection 2024 Jun 15.
8
Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer.肿瘤来源细胞外囊泡的对接和摄取所涉及的分子决定因素:在癌症中的意义。
Int J Mol Sci. 2024 Mar 19;25(6):3449. doi: 10.3390/ijms25063449.
9
Extracellular Vesicles: A New Star for Gene Drug Delivery.细胞外囊泡:基因药物递送的新星
Int J Nanomedicine. 2024 Mar 6;19:2241-2264. doi: 10.2147/IJN.S446224. eCollection 2024.
10
Extracellular Vesicle MicroRNA in the Kidney.肾脏细胞外囊泡 microRNA
Compr Physiol. 2023 Jun 26;13(3):4833-4850. doi: 10.1002/cphy.c220023.
细胞外囊泡作为癌症治疗的天然治疗剂和固有药物递送系统:最新进展、当前障碍及临床转化面临的挑战
Semin Cancer Biol. 2022 May;80:340-355. doi: 10.1016/j.semcancer.2020.08.007. Epub 2020 Sep 22.
4
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer.外泌体递送的 c-Met siRNA 可逆转胃癌对顺铂的化疗耐药性。
Int J Nanomedicine. 2020 Apr 1;15:2323-2335. doi: 10.2147/IJN.S231214. eCollection 2020.
5
Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo.人肝干细胞来源的细胞外囊泡在体内外抑制肾癌细胞干细胞来源的肿瘤生长。
Int J Cancer. 2020 Sep 15;147(6):1694-1706. doi: 10.1002/ijc.32925. Epub 2020 Feb 25.
6
Extracellular vesicles: a new communication paradigm?细胞外囊泡:一种新的通讯模式?
Nat Rev Mol Cell Biol. 2019 Sep;20(9):509-510. doi: 10.1038/s41580-019-0158-7.
7
Advances in therapeutic applications of extracellular vesicles.细胞外囊泡治疗应用的新进展。
Sci Transl Med. 2019 May 15;11(492). doi: 10.1126/scitranslmed.aav8521.
8
Renal Regenerative Potential of Extracellular Vesicles Derived from miRNA-Engineered Mesenchymal Stromal Cells.miRNA 工程化间充质基质细胞衍生的细胞外囊泡的肾脏再生潜能。
Int J Mol Sci. 2019 May 14;20(10):2381. doi: 10.3390/ijms20102381.
9
Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs.改善血浆来源细胞外囊泡的负载以封装抗肿瘤微小RNA。
Mol Ther Methods Clin Dev. 2019 Jan 9;13:133-144. doi: 10.1016/j.omtm.2019.01.001. eCollection 2019 Jun 14.
10
Human liver stem cell-derived extracellular vesicles enhance cancer stem cell sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN combined modulation.人肝干细胞衍生的细胞外囊泡通过Akt/mTOR/PTEN联合调节增强癌症干细胞对酪氨酸激酶抑制剂的敏感性。
Oncotarget. 2018 Nov 16;9(90):36151-36165. doi: 10.18632/oncotarget.26319.